SCHEMBL13049682

SCHEMBL13049682

COc1ncc(-c2oc3ccccc3c2CO)c(OC)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.44
▸ CES1 P23141 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA2 P47869 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ QPCT Q16769 1/20 0.36
▸ QPCTL Q9NXS2 1/20 0.36
▸ BRAF P15056 3/20 0.34
▸ ABCG2 Q9UNQ0 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767625 0.71 QPCT (0.54) FAAHCES1MAPTKDM4EALDH1A1
SCHEMBL30463591 0.70 FAAH (0.45) FAAHCES1MAPTKDM4EALDH1A1
SCHEMBL29225233 0.70 FAAH (0.45) FAAHCES1MAPTKDM4EALDH1A1
SCHEMBL13049683 0.68 AKR1C3 (0.46) MAPTKDM4EALDH1A1CYP3A4HSD17B10
SCHEMBL13049735 0.67 ABCG2 (0.52) MAPTKDM4EALDH1A1CYP3A4HSD17B10
SCHEMBL3560846 0.66 QPCT (0.40) FAAHCES1GABRG2GABRB3GABRA2
SCHEMBL2962849 0.66 KMT2A (0.53) MAPTKDM4EALDH1A1CYP3A4HSD17B10
SCHEMBL13920403 0.66 PDE4A (0.39) FAAHCES1GABRG2GABRB3GABRA2
SCHEMBL3564444 0.66 QPCT (0.45) FAAHCES1MAPTGABRG2GABRB3
SCHEMBL30970996 0.65 QPCT (0.42) FAAHCES1GABRG2GABRB3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7837981-B2 Methods for imaging soluble A-beta GENERAL ELECTRIC COMPANY (US) 2010-11-23 — — US disclosed
US-7837981-B2 Methods for imaging soluble A-beta GENERAL ELECTRIC COMPANY (US) 2010-11-23 — — US disclosed
EP-1631561-B1 COMPOSITIONS AND METHODS FOR NON-INVASIVE IMAGING OF SOLUBLE BETA-AMYLOID GEN ELECTRIC (US) 2010-08-18 — — EP disclosed
US-7727511-B2 Agents for imaging soluble a-beta GENERAL ELECTRIC COMPANY (US) 2010-06-01 — — US disclosed
US-7727511-B2 Agents for imaging soluble a-beta GENERAL ELECTRIC COMPANY (US) 2010-06-01 — — US disclosed
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-08-16 — — US disclosed
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-08-16 — — US disclosed
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-06-21 — — US disclosed
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA APBA1, APP, FABP7 FAAH 1345/4885CES1 2336/4885L3MBTL1 1694/4885
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA APBA1, APP, FABP7 FAAH 1342/4885CES1 2809/4885L3MBTL1 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback